| abstract |
To provide an antibody against human angiopoietin 2 (anti-AHG-2 antibody), a method for producing the same, a pharmaceutical composition containing the antibody, and a method for using the same. Specific to human angiopoietin-2 (ANG-2), comprising a specific amino acid sequence as a heavy chain variable region CDR3 region and a specific amino acid sequence as a light chain variable region Binding antibody. And an expression vector containing a nucleic acid for expressing the antibody in a prokaryotic host cell or eukaryotic host cell, and a prokaryotic host cell or eukaryotic host cell containing the vector. The antibody does not bind to ANG-1. [Selection figure] None |